PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
14-Dec-2023 Marinomed Biotech AG with new Carragelose distribution and manufacturing partners and EU patent Marinomed Biotech AG
14-Dec-2023 Evotec enters partnership with Charité to expand molecular patient database in autoimmune diseases Evotec SE
14-Dec-2023 MorphoSys Places New Shares from Cash Capital Increase with Gross Proceeds of Approximately EUR 102.7 Million MorphoSys AG
14-Dec-2023 Ad hoc: MorphoSys AG Places New Shares From Cash Capital Increase with Gross Proceeds Of Approximately EUR 102.7 million MorphoSys AG
14-Dec-2023 Acrometa Signs Strategic Cooperation Framework Agreement to Develop Co-Working Lab Space in China AcroMeta Group Limited
13-Dec-2023 Ad hoc: MorphoSys AG Launches Cash Capital Increase by way of Accelerated Bookbuilding Process MorphoSys AG
13-Dec-2023 Drägerwerk AG & Co. KGaA: Annual forecast raised again Drägerwerk AG & Co. KGaA
13-Dec-2023 Drägerwerk AG & Co. KGaA: Annual forecast raised again Drägerwerk AG & Co. KGaA
13-Dec-2023 Veranova Strengthens Leadership Further by Welcoming Lucas Sauer-Jones as Vice President & General Manager, New England Veranova
13-Dec-2023 Original-Research: Haemato AG (von First Berlin Equity Research GmbH) Haemato AG
13-Dec-2023 Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH) MPH Health Care AG
12-Dec-2023 Mainz Biomed Showcases ColoAlert® at Two Prominent Gastroenterology Conferences in Poland Mainz BioMed N.V.
12-Dec-2023 ANTABIO Raises €25 Million in Series B Financing B3C newswire
12-Dec-2023 ViroCell signs manufacturing services agreement with UCL to accelerate research into prevention of relapse in childhood blood cancer ViroCell
12-Dec-2023 Almirall and etherna enter into a multi-target alliance to develop mRNA-based therapies in medical dermatology Almirall
12-Dec-2023 Jose Ibietatorremendia to Join Veranova as SVP, General Counsel, and Secretary SVP
12-Dec-2023 Astraveus appoints Dr. Lars Henrik Peeck as Chief Business Development Officer Astraveus
12-Dec-2023 Biotest expands its clinical development program for trimodulin to patients with community-acquired pneumonia (CAP) Biotest AG
12-Dec-2023 DEFENCE RECEIVES FDA APPROVAL FOR PHASE I CLINICAL TRIAL TARGETING SOLID CANCER TUMORS WITH ACCUTOX® Defence Therapeutics Inc.
11-Dec-2023 Tryp Therapeutics Inc. Announces Signing of Definitive Agreement with Exopharm Limited Tryp Therapeutics Inc.